Information Statements

Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease— state-of-the-evidence and clinical recommendations

Guidance and Best Practices for Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC and SNMMI

Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI

Update on Guidance and Best Practices for Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: Emphasis on Transition to Chronic Endemic State

ASNC model coverage policy: 2023 cardiac positron emission tomography

This content is an exclusive benefit for ASNC members. If you’re an ASNC member, log in and you’ll get immediate access. If you’re not yet an ASNC member, you’ll be…

Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice

Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology J Nucl Cardiol. 2023;30:2850-2906. Panithaya Chareonthaitawee,…

An ASNC Information Statement: Radiopharmaceutical supply disruptions

An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis READ NOW

ASNC imaging guidelines for nuclear cardiology procedures

PET myocardial perfusion and metabolism clinical imaging Vasken Dilsizian, MD,a Stephen L. Bacharach, PhD,b Robert S. Beanlands, MD,c Steven R. Bergmann, MD, PhD,d Dominique Delbeke, MD,e Robert J. Gropler, MD,f…

ASNC Issues Statement on How to Use HMDP in Cardiac Amyloidosis Imaging

ASNC Issues Statement on How to Use HMDP in Cardiac Amyloidosis Imaging Shortages of pyrophosphate used to prepare 99mTc-PYP, the radiopharmaceutical most commonly used in the U.S. for noninvasive diagnosis…

ASNC Statements of Principles on the Issue of Multimodality Imaging

ASNC Statements of Principles on the Issue of Multimodality Imaging Randall C. Thompson, MD, FASNC,a Dennis A. Calnon, MD, MASNC,b Donna M. Polk, MD, MPH, FASNC,e Mouaz H. Al-Mallah, MD,…

Ready to Join Us?